Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CD276 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD276 expression	Clear Cell Renal Cell Carcinoma	CD276 expression	Clear Cell Renal Cell Carcinoma	Immunotherapy Resistant: C3 – Early Trials Diagn Pathol - 3 weeks (New C3) Immunotherapy Resistant : C3 Diagn Pathol - 3wk	Immunotherapy Resistant: C3 – Early Trials Diagn Pathol - 3 weeks Immunotherapy Resistant : C3 Diagn Pathol - 3 weeks - (New C3)
CD276 expression	Head and Neck Cancer	CD276 expression	Head and Neck Cancer	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D
CD276 expression	Breast Cancer	CD276 expression	Breast Cancer	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D
CD276 expression	Acute Myelogenous Leukemia	CD276 expression	Acute Myelogenous Leukemia	s Sensitive: D – Preclinical s Sensitive : D	s Sensitive: D – Preclinical s Sensitive : D
CD276 expression	Neuroblastoma	CD276 expression	Neuroblastoma	B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical B7-H3-targeted antibody-drug conjugate Sensitive : D	B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical B7-H3-targeted antibody-drug conjugate Sensitive : D
CD276 expression	Pancreatic Ductal Adenocarcinoma	CD276 expression	Pancreatic Ductal Adenocarcinoma	B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical B7-H3-targeted antibody-drug conjugate Sensitive : D	B7-H3-targeted antibody-drug conjugate Sensitive: D – Preclinical B7-H3-targeted antibody-drug conjugate Sensitive : D
CD276 expression	Prostate Cancer	CD276 expression	Prostate Cancer	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D	MGC018 Sensitive: D – Preclinical MGC018 Sensitive : D